Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, for its next-generation...
Search results for "drugs"
Even Seoul-Area Tertiary Hospitals Fall Into the Red as 253 Institutions Record a Nine-Year Financial Slide
It is a familiar refrain in the healthcare industry that managing hospital finances has grown exceptionally difficult.
National University Hospitals Shift to Health Ministry After 21 Years to Lead Regional Care
Supervisory authority over South Korea’s national university and dental hospitals will officially transfer from the...
Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization
Stockout cases have dropped sharply at Hanmi Pharmaceutical’s primary manufacturing base for synthetic drugs.
Why Stage 3 Breast Cancer Doesn’t Always Mean Immediate Surgery
“Shouldn’t it be removed as soon as possible — even a day sooner?” This reaction is common among patients and their...
550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair
With national health insurance coverage for the new pulmonary arterial hypertension treatment Winrevair (active...
'I'm Afraid I'll Fall': Smartphone AI Flags 86% of Older Adults at Risk for Locomotive Syndrome
Editor’s note: In Japan’s orthopedic community, specialists use the term "locomotive syndrome" to describe a decline in...
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million...
HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use
HK inno.N’s gastroesophageal reflux disease drug K-CAB has expanded its approved uses to include the prevention of...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...